Sodium Polystyrene Sulfonate
NDC 35573-108, sodium polystyrene sulfonate, suspension, from Burel Pharmaceuticals, LLC.
- Product NDC
- 35573-108
- Status
- Listed
- Labeler
- Burel Pharmaceuticals, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL, RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214912
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/35573-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM POLYSTYRENE SULFONATE15 g/60mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 35573-108-14 | 35573010814 | 10 BOTTLE, UNIT-DOSE in 1 CARTON (35573-108-14) / 60 mL in 1 BOTTLE, UNIT-DOSE (35573-108-13) |
| 35573-108-57 | 35573010857 | 473 mL in 1 BOTTLE (35573-108-57) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8bbeae67-a7ff-4fa6-b21e-fb8617cd9197
Use it
Look up 35573-108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/35573-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 35573-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.